$448.4 K

BIEI Mkt cap, 08-Oct-2018

$8.2 K

Premier Biomedical Revenue Q3, 2018
Premier Biomedical Gross profit (Q3, 2018)3.9 K
Premier Biomedical Gross profit margin (Q3, 2018), %46.8%
Premier Biomedical Net income (Q3, 2018)-363.5 K
Premier Biomedical Cash, 30-Sep-201863.2 K

Premier Biomedical Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

39.8k

Cost of goods sold

25.4k

Gross profit

14.3k

Gross profit Margin, %

36%

R&D expense

217.4k196.2k234.1k113.9k184.3k

General and administrative expense

3.0m223.4k133.3k191.4k196.7k

Operating expense total

4.5m419.6k2.4m637.9k1.3m

Interest expense

400.4k41.6k198.9k817.4k351.5k

Net Income

(4.9m)(1.4m)(2.6m)(1.8m)(3.8m)

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

24.3k10.4k12.1k8.2k

Cost of goods sold

11.1k6.1k10.1k4.4k

Gross profit

13.2k4.3k1.9k3.9k

Gross profit Margin, %

54%42%16%47%

R&D expense

58.5k2.7k52.2k56.9k59.7k10.1k49.5k46.1k184.3k

General and administrative expense

666.9k47.8k40.3k25.5k44.8k49.5k42.0k36.6k40.2k37.0k34.5k42.8k62.6k

Operating expense total

1.0m277.9k209.8k82.4k140.2k59.6k179.0k151.2k85.9k243.6k74.1k81.5k85.2k

Interest expense

8.0k29.5k49.6k48.5k217.1k202.4k284.0k600.037.1k64.1k73.6k184.6k

Net Income

(1.0m)(307.3k)(209.8k)(936.6k)(188.8k)(415.1k)(722.1k)(435.1k)(1.2m)3.7m566.3k(100.0k)(363.5k)

Premier Biomedical Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

15.8k102.6k35.4k22.4k83.7k

Accounts Receivable

171.5m312.0

Inventories

84.8k

Current Assets

21.8k115.5k66.5k33.9k203.6k

PP&E

3.7k5.1k3.6k5.1k5.5k

Total Assets

25.5k120.6k70.2k39.0k209.1k

Accounts Payable

122.3k147.5k188.3k220.7k346.8k

Current Liabilities

274.5k188.4k346.5k699.7k2.8m

Total Liabilities

346.5k699.7k2.8m

Additional Paid-in Capital

6.5m8.1m10.5m11.9m13.4m

Retained Earnings

(8.2m)(10.8m)(12.6m)(16.3m)

Total Equity

(249.0k)(67.8k)(276.3k)(660.7k)(2.6m)

Financial Leverage

-0.1 x-1.8 x-0.3 x-0.1 x-0.1 x

Premier Biomedical Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(4.9m)(1.4m)(2.6m)(1.8m)(3.8m)

Depreciation and Amortization

767.0954.01.5k2.1k2.3k

Accounts Receivable

(312.0)

Inventories

(84.8k)

Accounts Payable

33.7k25.2k40.8k32.5k126.1k

Cash From Operating Activities

(428.2k)(639.1k)(462.2k)(483.6k)(509.4k)

Purchases of PP&E

(1.4k)(2.4k)(3.5k)(2.7k)

Cash From Investing Activities

(1.4k)(2.4k)(3.5k)(2.7k)

Cash From Financing Activities

405.1k728.3k395.0k474.2k573.4k

Interest Paid

20.8k32.6k13.5k5.6k

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2018

Net Income

(307.3k)(209.8k)(936.6k)(188.8k)(415.1k)(722.1k)(435.1k)566.3k

Depreciation and Amortization

233.0466.0591.0

Accounts Receivable

312.0

Inventories

5.4k

Accounts Payable

(104.6k)(79.6k)34.6k209.5k237.9k299.4k83.4k143.7k210.1k42.0

Cash From Operating Activities

(304.5k)(418.6k)(62.5k)

Purchases of PP&E

(2.0k)

Cash From Investing Activities

(2.0k)

Cash From Financing Activities

402.3k602.3k60.0k

Interest Paid

32.6k32.6k

Premier Biomedical Ratios

USDY, 2018

Financial Leverage

-0.1 x
Report incorrect company information